Navigation Links
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
Date:10/24/2007

, safety, tolerability and food effect of R7128 in healthy volunteers and in patients chronically infected with HCV genotype 1. This adaptive Phase 1 study is comprised of three parts:

Part 1 is a single ascending dose study of R7128 conducted in 46 healthy volunteers. The primary objective of Part 1 is to assess the safety, tolerability and pharmacokinetics of R7128 following single ascending doses under fasting conditions. The secondary objective of Part 1 is to explore the effect of food on the pharmacokinetics of R7128. Results from the single ascending dose portion of the study indicated that all doses of R7128 studied (500 mg to 9000 mg) were generally safe and well-tolerated. All patients completed the study, and none experienced gastrointestinal adverse events or serious adverse events during the study. No hematological or laboratory abnormalities of clinical significance were noted.

Part 2 is a multiple ascending dose study of R7128 conducted in 40 patients chronically-infected with HCV genotype 1 who previously failed interferon therapy. The primary objective of Part 2 is to assess the safety, tolerability and pharmacokinetics of R7128 after once-daily (QD) or twice- daily (BID) dosing for 14 days. The secondary objective is to assess antiviral activity by measuring the change in HCV RNA. Preliminary data from the multiple ascending dose portion of the study indicated that R7128 demonstrated potent, dose-dependent antiviral activity in four patient cohorts receiving 750 mg or 1500 mg administered either once-daily or twice-daily for 14 days as monotherapy. Patients receiving 1500 mg BID demonstrated a mean 2.7 log10 IU/mL (>99%) decrease in HCV RNA. There was no evidence of viral rebound in any dose cohort during the 14 days of dosing. R7128 was generally safe and well tolerated. There were no serious adverse events, no adverse events requiring dose modification, no dose-related gastrointestinal adverse events and no clinically significant chan
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
5. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
9. Staphylococcus aureus vaccine development on track ? safe and immunogenic in Phase I clinicaltrials
10. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
11. Point of Care Strep Tests Speed Treatment, Lower Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015   Bernstein Liebhard LLP ... or the "Company") (NASDAQ: AERI ) issued ... violation of the federal securities laws; or (ii) ... fiduciary duties to shareholders. Aerie is ... development and commercialization of first-in-class therapies for the ...
(Date:4/24/2015)... April 24, 2015 Allowing more basic emergency ... drug overdose deaths that involve opioids, according to a ... in Naloxone Administration by Emergency Medical Service Providers and ... in the American Journal of Public Health . ... the United States involved prescription ...
(Date:4/24/2015)... April 24, 2015  A new study shows an "alarming ... drugs used to slow the progression of multiple sclerosis or ... by researchers at Oregon Health & Science University (OHSU) and ... the number of MS drugs in the marketplace over the ... stabilized costs for patients who use those drugs. Researchers found ...
Breaking Medicine Technology:Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
... 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's leading drug ... I trial of BL-1020, the first GABA,enhanced ... The trial demonstrated that the compound was ... which is indicative of efficacy. BioLineRx presented ...
... -- Auxilium,Pharmaceuticals, Inc. today announced that new ... energy levels and,erectile function in 76 percent ... replacement gel therapy. Total testosterone,levels increased significantly ... (testosterone gel) following suboptimal,response to Solvay S.A.'s ...
Cached Medicine Technology:BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
(Date:4/24/2015)... 2015 Bird B Gone, the leader in ... offers a complete line of bird control solutions to address ... New Flu Strains Threaten Pacific, Central and Mississippi Farms , ... , a number of highly pathogenic avian flus in the ... often spread when wild birds enter poultry farms. The USDA ...
(Date:4/24/2015)... Ranch, California (PRWEB) April 24, 2015 ... has a wide range of capabilities and services to ... , Ryadon's Quantity Discount Program will be offered ... as follows: , Order 4-19: Receive 10% discount - ... Benefit by Using the Drawer Slides Products, ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 The 1975 ... toured almost constantly across the globe to theaters, festivals and ... in Manchester, they’ve partnered with their label, Dirty Hit Records, ... Teaming up with the newly launched Cadence & Cause ... their debut LP on vinyl and a signed photo card. ...
(Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog post has ... qualify for auto insurance as a single parent. ... online, without having to follow a special process. The ... reduce their auto insurance expenses. The tips are presented ... , Clients can now visit an insurance brokerage website ...
(Date:4/24/2015)... “Kind,” “selfless,” “the voice of reason” and “truly ... described pediatric oncology nurse Laura Vasquez of Children’s Hospital ... her five-year battle with a malignant brain tumor. Through ... numerous experimental treatments, Vasquez continued caring for Alexa, stopping ... not in the hospital and even sitting vigil during ...
Breaking Medicine News(10 mins):Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4
... Quantum Group,Inc. (NYSE Alternext US: QGP) ( www.QuantumMD.com ... today that it supports the American,Recovery and Reinvestment ... The Quantum Group President ... few weeks Congress will be considering the American ...
... SAN DIEGO, Jan. 20 BioMed Realty Trust, Inc. (NYSE: BMR ) today announced the tax treatment of its 2008 distributions as follows:, ... CUSIP: 09063H107, ... ... Record Payable Distribution Allocable Ordinary, ...
... still entitled to before you leave can save you money, improve your ... ... -- Each year, millions of Americans are diagnosed with permanent or long-term ... Too often, however, people simply quit their jobs without knowing their rights, ...
... ... Wayne, New Jersey (PRWEB) January 20, 2009 ... record increases in new accounts and overall usage of it,s automated ... given more companies more reason to look for cost cutting measures. ...
... hearing system uses innovative technology to improve speech ... Phonak, the world,s leading manufacturer of ... Audeo YES, people with hearing loss are once ... life as the world,s smallest completely wireless hearing ...
... as RECIST, used by clinicians to measure tumour size ... 20 January) in a special issue of the European ... revisions will ease the workload involved in running clinical ... Criteria in Solid Tumours) were first published in 2000 ...
Cached Medicine News:Health News:The Quantum Group Announces Support of Technology Bill Before Congress 2Health News:The Quantum Group Announces Support of Technology Bill Before Congress 3Health News:The Quantum Group Announces Support of Technology Bill Before Congress 4Health News:BioMed Realty Trust Announces Tax Treatment of 2008 Distributions 2Health News:BioMed Realty Trust Announces Tax Treatment of 2008 Distributions 3Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 2Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 3Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 4Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 5Health News:Allsup Outlines Rights of People Leaving Work Due to a Disability 6Health News:Conf$ave Announces Record Growth By Providing Substantial Savings To Customers 2Health News:Enjoy the Full Sound Spectrum in a Stylish Way, with Audeo YES 2Health News:Enjoy the Full Sound Spectrum in a Stylish Way, with Audeo YES 3Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 2Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 3Health News:New criteria for measuring tumor size and progression will help ease workloads in clinical trials 4
The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono...
Used for arthroscopic or open shoulder surgery. Powered positioning of back section inclines from 0 degrees to 90 degrees. Removable shoulder panels provide an eight-inch (203-mm) access area behind ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
Medicine Products: